0001213900-16-009897.txt : 20160104
0001213900-16-009897.hdr.sgml : 20160104
20160104173032
ACCESSION NUMBER: 0001213900-16-009897
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151231
FILED AS OF DATE: 20160104
DATE AS OF CHANGE: 20160104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLIGENIX, INC.
CENTRAL INDEX KEY: 0000812796
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 411505029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-538-8200
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DOR BIOPHARMA INC
DATE OF NAME CHANGE: 20020329
FORMER COMPANY:
FORMER CONFORMED NAME: ENDOREX CORP
DATE OF NAME CHANGE: 19960916
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Straube Richard
CENTRAL INDEX KEY: 0001595197
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-16929
FILM NUMBER: 161319303
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE, SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
f4123115straube_soligenix.xml
OWNERSHIP DOCUMENT
X0306
4
2015-12-31
0
0000812796
SOLIGENIX, INC.
SNGX
0001595197
Straube Richard
29 EMMONS DRIVE, SUITE C-10
PRINCETON
NJ
08540
0
1
0
0
Senior VP and CMO
Stock Option (Right to Buy)
1.13
2015-12-31
4
A
0
70000
0
A
2015-12-31
2025-12-30
Common Stock
70000
70000
D
The stock option vested immediately as to 17,500 shares and vests as to the remainder at a rate of 6.25% of the total shares underlying the stock option on each three (3) month anniversary of December 31, 2015.
/s/ Richard Straube
2016-01-04